As of January 23, 2025, Aprea Therapeutics (APRE) has a market cap of $21.794 million USD. According to our data, Aprea Therapeutics is ranked No.8580 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $21.79 M |
21.88%
|
Dec 31, 2024 | $17.88 M |
-30.00%
|
Dec 29, 2023 | $25.54 M |
-29.00%
|
Dec 30, 2022 | $35.98 M |
-88.47%
|
Dec 31, 2021 | $0.31 B |
-41.67%
|
Dec 31, 2020 | $0.53 B |
-89.28%
|
Dec 31, 2019 | $4.99 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Market Cap | = | APRE Stock Price | * | APRE Shares Outstanding |
= | $4.01 | * | 5.43 M | |
= | $21.79 M |